BioGaia AB Statistics

Total Valuation

BioGaia AB has a market cap or net worth of GBP 826.17 million. The enterprise value is 730.37 million.

Market Cap	826.17M
Enterprise Value	730.37M

Important Dates

The next estimated earnings date is Friday, July 18, 2025.

Earnings Date	Jul 18, 2025
Ex-Dividend Date	May 8, 2025

Share Statistics

Current Share Class	98.50M
Shares Outstanding	n/a
Shares Change (YoY)	+0.13%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	73.43M

Valuation Ratios

The trailing PE ratio is 34.59 and the forward PE ratio is 27.16.

PE Ratio	34.59
Forward PE	27.16
PS Ratio	7.55
PB Ratio	6.02
P/TBV Ratio	6.62
P/FCF Ratio	30.50
P/OCF Ratio	30.01
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 21.62, with an EV/FCF ratio of 26.96.

EV / Earnings	30.58
EV / Sales	6.71
EV / EBITDA	21.62
EV / EBIT	22.98
EV / FCF	26.96

Financial Position

The company has a current ratio of 10.84

Current Ratio	10.84
Quick Ratio	8.31
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	206.82

Financial Efficiency

Return on equity (ROE) is 15.69% and return on invested capital (ROIC) is 13.13%.

Return on Equity (ROE)	15.69%
Return on Assets (ROA)	11.48%
Return on Invested Capital (ROIC)	13.13%
Return on Capital Employed (ROCE)	22.02%
Revenue Per Employee	488,526
Profits Per Employee	106,621
Employee Count	225
Asset Turnover	0.63
Inventory Turnover	n/a

Taxes

In the past 12 months, BioGaia AB has paid 6.66 million in taxes.

Income Tax	6.66M
Effective Tax Rate	21.81%

Stock Price Statistics

The stock price has decreased by -14.76% in the last 52 weeks. The beta is 0.62, so BioGaia AB's price volatility has been lower than the market average.

Beta (5Y)	0.62
52-Week Price Change	-14.76%
50-Day Moving Average	103.03
200-Day Moving Average	109.93
Relative Strength Index (RSI)	60.49
Average Volume (20 Days)	8,823

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BioGaia AB had revenue of GBP 109.43 million and earned 23.88 million in profits. Earnings per share was 0.24.

Revenue	109.43M
Gross Profit	79.67M
Operating Income	31.96M
Pretax Income	30.54M
Net Income	23.88M
EBITDA	33.28M
EBIT	31.96M
Earnings Per Share (EPS)	0.24

Full Income Statement

Balance Sheet

The company has 96.33 million in cash and n/a in debt, giving a net cash position of 96.33 million.

Cash & Cash Equivalents	96.33M
Total Debt	n/a
Net Cash	96.33M
Net Cash Per Share	n/a
Equity (Book Value)	137.18M
Book Value Per Share	1.36
Working Capital	114.04M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 27.53 million and capital expenditures -436,582, giving a free cash flow of 27.09 million.

Operating Cash Flow	27.53M
Capital Expenditures	-436,582
Free Cash Flow	27.09M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 72.81%, with operating and profit margins of 29.20% and 21.83%.

Gross Margin	72.81%
Operating Margin	29.20%
Pretax Margin	27.91%
Profit Margin	21.83%
EBITDA Margin	30.41%
EBIT Margin	29.20%
FCF Margin	24.76%

Dividends & Yields

This stock pays an annual dividend of 0.54, which amounts to a dividend yield of 0.52%.

Dividend Per Share	0.54
Dividend Yield	0.52%
Dividend Growth (YoY)	5.77%
Years of Dividend Growth	1
Payout Ratio	61.94%
Buyback Yield	-0.13%
Shareholder Yield	0.39%
Earnings Yield	2.89%
FCF Yield	3.28%

Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on May 18, 2022. It was a forward split with a ratio of 5.

Last Split Date	May 18, 2022
Split Type	Forward
Split Ratio	5

Scores

Altman Z-Score	n/a
Piotroski F-Score	6